26.66
Precedente Chiudi:
$24.00
Aprire:
$24.4
Volume 24 ore:
47,457
Relative Volume:
4.36
Capitalizzazione di mercato:
$242.57M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+8.82%
1M Prestazione:
+142.36%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Research Alliance Corp Iii Stock (RACC) Company Profile
Nome
Research Alliance Corp Iii
Settore
Industria
Telefono
(617) 778-2500
Indirizzo
600 FIFTH AVENUE, 23RD FLOOR, NEW YORK
Compare RACC vs LION, XXI, UMAC, CCXI, EVAC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
RACC
Research Alliance Corp Iii
|
26.66 | 120.78M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
11.87 | 3.86B | 2.63B | -175.60M | 11.40M | -0.7173 |
|
XXI
Twenty One Capital Inc
|
4.50 | 1.57B | 0 | 4.35M | 456.40K | 0.3397 |
|
UMAC
Unusual Machines Inc
|
25.97 | 984.55M | 17.25M | -5.64M | -40.16M | -0.3337 |
|
CCXI
Churchill Capital Corp Xi
|
16.37 | 764.20M | 0 | 0 | 0 | 0.0647 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.25 | 597.92M | 0 | 12.80M | -714.00K | 0.2184 |
Research Alliance Corp Iii Borsa (RACC) Ultime notizie
OHB Pediatrics Ltd. entered into a definitive business combination agreement to acquire Research Alliance Corporation III from Research Alliance Holdings III LLC and others for approximately $160 million in a reverse merger transaction. - marketscreener.com
RA Capital launches Oak Hill Bio onto the Nasdaq via SPAC - Fierce Biotech
OHB Pediatrics to go public through Research Alliance Corporation III pact - TipRanks
Oak Hill Bio goes public with ~$175M in proceeds - The Pharma Letter
RA Capital-backed SPAC Research Alliance Corp III agrees to merge with Oak Hill Bio in USD 175 million deal - Bitget
Sierra Bancorp Q2 FY26 net income falls 7% to $9.9 million; revenue dips 1% to $39 million - Bitget
Iberdrola secures EUR 29 million EIB green loan for Labraza wind farm development - Bitget
Form 4 Research Alliance Corporation III For: 27 July By Investing.com - Investing.com Nigeria
EDGAR Filing Documents for 0001193125-26-316960 - SEC.gov
EDGAR Filing Documents for 0001193125-26-316954 - SEC.gov
Research Alliance to Acquire OHB Pediatrics in Stock Deal Valued at $160 Million Plus SAFEs - TradingView
Oak Hill Bio, Research Alliance III (RACC) plan SPAC merger - Stock Titan
Oak Hill Bio and Research Alliance Corporation III Announce - GlobeNewswire
RACC|Research Alliance III Ord Shs Class A|Price:11.000|Chg%:-0.250 - TradingKey
Research Alliance Corporation IV Revenue Breakdown – NASDAQ:RACD - TradingView
Enterprise value to revenue forward of Research Alliance Corporation III – NASDAQ:RACC - TradingView
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology - The American Journal of Managed Care® (AJMC®)
Meridia RE IV Socimi announces EUR 0.01 per share dividend for 2025 results - Bitget
COMMODORE CAPITAL LP Acquires 500,000 Shares in Research Alliance Corp IV - GuruFocus
Wesfarmers Price Target Raised 2% to A$88.00/Share by Macquarie - Bitget
RACD: Research Alliance Corporation IVFull Company Report - Zacks Investment Research
Henry William Stusnick Net Worth (2026) - GuruFocus
Research Alliance Holdings Iii Llc /cayman Net Worth (2026) - GuruFocus
Francis Sherman Adams Net Worth (2026) - GuruFocus
Research Alliance Corporation III (RACC) Stock Price, News & Analysis - MarketBeat
Research Alliance Holdings IV LLC Discloses Investment in Research Alliance Corporation IV with 17% Stake - TradingView
Research Alliance Corporation IV (RACD) sponsor reports 17% ownership - Stock Titan
Research Alliance Corp IV (RACD) investor group reports 5.5% ownership of Class A shares - Stock Titan
Biotechnology Value Fund (RACD) group reveals 6.4% Research Alliance stake - Stock Titan
Research Alliance Corporation IV Completes Initial Public Offering - TipRanks
Research Alliance IV prices IPO for $75M, deposits $75M trust; sponsor buys $2.75M private placement - TradingView
Commodore Capital takes 5.5% position in Research Alliance Corp IV (RACD) - Stock Titan
RACD Stock Latest News - TipRanks
Perceptive Advisors reports 7.7% RACD stake in Research Alliance Corporation IV (RACD) - Stock Titan
Frontier tech research, news & data - MLQ.ai
RACD SEC FilingsResearch Alliance Corp IV 10-K, 10-Q, 8-K Forms - Stock Titan
Research Alliance Corporation IV (RACD) Stock Price, News & Analysis - MarketBeat
Research Alliance Corporation IV (RACD) stock historical prices and data - Yahoo Finance Australia
Cash flow from operating activities of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corporation IV (RACD) Stock Chart and Price History 2026 - MarketBeat
Research Alliance Corp IV (RACD) grants 275,000 shares to director entity - Stock Titan
Research Alliance Corp IV (RACD) sponsor gets 275K share grant - Stock Titan
Research Alliance Corporation IV (RACD) seeks $75M SPAC IPO - Stock Titan
Book value per share of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
RACD Price Today: Research Alliance Corporation IV Stock Price, Quote & Chart - MEXC
Cash flow from investing activities of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corporation IV (RACD) 10K Form and Latest SEC Filings 2026 - MarketBeat
Research Alliance Corporation IV Prices $75 Million IPO, Targets Healthcare Sector on Nasdaq - Minichart
Research Alliance IV Completes $75 Million SPAC IPO, Inks Trust, Underwriting and $2.75 Million Private Deal - TradingView
Research Alliance Corporation IV (RACD) completes $75M IPO and trust funding - Stock Titan
Research Alliance Corp IV SEC Filing (Jul 13, 2026) - Stock Titan
Research Alliance Corp Iii Azioni (RACC) Dati Finanziari
Non sono disponibili dati finanziari per Research Alliance Corp Iii (RACC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):